AtriCure (ATRC) Revenue (2010 - 2026)

AtriCure (ATRC) has 17 years of Revenue data on file, last reported at $141.2 million in Q1 2026.

• Revenue for Q1 2026 came in at $141.2 million, up 14.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $552.2 million (up 15.01% YoY), and the FY2025 annual result was $534.5 million, up 14.88% from the prior year.
• Revenue climbed to $141.2 million in Q1 2026 per ATRC's latest filing, from $140.5 million in the prior quarter.
• Over five years, Revenue peaked at $141.2 million in Q1 2026 and troughed at $74.6 million in Q1 2022.
• A 5-year average of $110.0 million and a median of $108.9 million in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2025: Revenue gained 25.81% in 2022, then rose 13.05% in 2025.
• A 5-year view of Revenue shows it stood at $88.0 million in 2022, then grew by 21.03% to $106.5 million in 2023, then increased by 16.64% to $124.3 million in 2024, then climbed by 13.05% to $140.5 million in 2025, then grew by 0.53% to $141.2 million in 2026.
• Business Quant data shows ATRC's Revenue at $141.2 million in Q1 2026, $140.5 million in Q4 2025, and $134.3 million in Q3 2025.